Head and neck cancer

Medical Clinics of North America

Volumn 94, Issue 5, 2010, Pages 1031-1046

  Crozier, Emily ^a   Sumer, Baran D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Head and neck cancers; Radiation therapy; Surgical excision

Indexed keywords

BEVACIZUMAB; CETUXIMAB; CYCLIN D1; PROTEIN P16; PROTEIN P53;

ANATOMY; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; DIAGNOSTIC VALUE; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; MOUTH CANCER; NASOPHARYNX CANCER; OROPHARYNX CANCER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; WART VIRUS;

BIOPSY, FINE-NEEDLE; EARACHE; HEAD AND NECK NEOPLASMS; HOARSENESS; HUMANS; OROPHARYNX; PALATE; PAPILLOMAVIRUS INFECTIONS; PHYSICAL EXAMINATION;

EID: 77955910349     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.05.014     Document Type: Review

References (63)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
2. Cohan D.M., Popat S., Kaplan S.E., et al. Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg 2009, 17(2):88-94.
3. Teppo H., Koivunen P., Hyrynkangas K., et al. Diagnostic delays in laryngeal carcinoma: professional diagnostic delay is a strong independent predictor of survival. Head Neck 2003, 25(5):389-394.
4. American Cancer Society Cancer facts and figures Available at:, Accessed December 30, 2009. http://www.cancer.org/downloads/STT/500809web.pdf.
5. Cooper J.S., Porter K., Mallin K., et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009, 31(6):748-758.
6. Talamini R., Bosetti C., La Vecchia C., et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 2002, 13(10):957-964.
7. Grandis J.R., Tweardy D.J. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993, 53(15):3579-3584.
8. Sok J.C., Coppelli F.M., Thomas S.M., et al. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res 2006, 12(17):5064-5073.
9. Mineta H., Miura K., Ogino T., et al. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 2000, 83(6):775-781.
10. Shiboski C.H., Schmidt B.L., Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005, 103(9):1843-1849.
11. Vidal L., Gillison M.L. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am 2008, 22(6):1125-1142. vii.
12. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92(9):709-720.
13. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356(19):1944-1956.
14. Chaturvedi A.K., Engels E.A., Anderson W.F., et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26(4):612-619.
15. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100(4):261-269.
16. Weinberger P.M., Yu Z., Haffty B.G., et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006, 24(5):736-747.
17. Rich J.T., Milov S., Lewis J.S., et al. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope 2009, 119(9):1709-1719.
18. Lindquist D., Romanitan M., Hammarstedt L., et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 2007, 1(3):350-355.
19. Hafkamp H.C., Manni J.J., Haesevoets A., et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008, 122(12):2656-2664.
20. Straetmans J.M., Olthof N., Mooren J.J., et al. Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 2009, 119(10):1951-1957.
21. Lassen P., Eriksen J.G., Hamilton-Dutoit S., et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009, 27(12):1992-1998.
22. Larsson L.G., Sandstrom A., Westling P. Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden. Cancer Res 1975, 35(11 Pt 2):3308-3316.
23. El-Serag H.B., Hepworth E.J., Lee P., et al. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol 2001, 96(7):2013-2018.
24. Vaezi M.F., Qadeer M.A., Lopez R., et al. Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med 2006, 119(9):768-776.
25. Qadeer M.A., Colabianchi N., Strome M., et al. Gastroesophageal reflux and laryngeal cancer: causation or association? A critical review. Am J Otolaryngol 2006, 27(2):119-128.
26. Qadeer M.A., Colabianchi N., Vaezi M.F. Is GERD a risk factor for laryngeal cancer?. Laryngoscope 2005, 115(3):486-491.
27. Kawaguchi H., El-Naggar A.K., Papadimitrakopoulou V., et al. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol 2008, 26(3):354-360.
28. Silverman S., Gorsky M., Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984, 53(3):563-568.
29. Barnard N.A., Scully C., Eveson J.W., et al. Oral cancer development in patients with oral lichen planus. J Oral Pathol Med 1993, 22(9):421-424.
30. Knappe M., Louw M., Gregor R.T. Ultrasonography-guided fine-needle aspiration for the assessment of cervical metastases. Arch Otolaryngol Head Neck Surg 2000, 126(9):1091-1096.
31. Tandon S., Shahab R., Benton J.I., et al. Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis. Head Neck 2008, 30(9):1246-1252.
32. Lassen U., Daugaard G., Eigtved A., et al. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT). Eur J Cancer 1999, 35(7):1076-1082.
33. National Cancer Institute Available at:, Accessed December 30, 2009. http://www.cancer.gov/.
34. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004, 22(1):69-76.
35. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991, 324(24):1685-1690.
36. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349(22):2091-2098.
37. Lefebvre J.L., Chevalier D., Luboinski B., et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996, 88(13):890-899.
38. Adelstein D.J., Saxton J.P., Rybicki L.A., et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 2006, 24(7):1064-1071.
39. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000, 355(9208):949-955.
40. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000, 88(4):876-883.
41. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998, 338(25):1798-1804.
42. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999, 91(24):2081-2086.
43. Cmelak A.J., Li S., Goldwasser M.A., et al. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 2007, 25(25):3971-3977.
44. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004, 350(19):1937-1944.
45. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004, 350(19):1945-1952.
46. Winquist E., Oliver T., Gilbert R. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis. Head Neck 2007, 29(1):38-46.
47. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005, 27(10):843-850.
48. Pradier O., Christiansen H., Schmidberger H., et al. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2005, 63(5):1368-1377.
49. Jackel M.C., Martin A., Steiner W. Twenty-five years experience with laser surgery for head and neck tumors: report of an international symposium, Gottingen, Germany, 2005. Eur Arch Otorhinolaryngol 2007, 264(6):577-585.
50. O'Malley B.W., Weinstein G.S., Snyder W., et al. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006, 116(8):1465-1472.
51. Genden E.M., Desai S., Sung C.K. Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck 2009, 31(3):283-289.
52. Park Y.M., Lee W.J., Lee J.G., et al. Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech A 2009, 19(3):361-368.
53. Hinni M.L., Salassa J.R., Grant D.G., et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007, 133(12):1198-1204.
54. Christiansen H., Hermann R.M., Martin A., et al. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2006, 65(4):1067-1074.
55. Steiner W., Vogt P., Ambrosch P., et al. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head Neck 2004, 26(6):477-484.
56. Steiner W., Ambrosch P., Hess C.F., et al. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 2001, 124(1):58-67.
57. Iro H., Waldfahrer F., Altendorf-Hofmann A., et al. Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg 1998, 124(11):1245-1250.
58. Steiner W., Fierek O., Ambrosch P., et al. Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 2003, 129(1):36-43.
59. Cozzi L., Fogliata A., Lomax A., et al. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001, 61(3):287-297.
60. Pignon J.P., Baujat B., Bourhis J. Cancer Radiother 2005, 9(1):31-36. [in French].
61. Pignon J.P., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data. Br J Cancer 1995, 72(4):1062-1063.
62. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354(6):567-578.
63. Ravasco P., Monteiro-Grillo I., Marques Vidal P., et al. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005, 27(8):659-668.